Innovative gold-catalyzed method for atomically rough surfaces shows promise in enhancing ethanol oxidation reaction ...

Cristcot, a clinical-stage pharmaceutical company advancing innovative therapies for gastrointestinal diseases, today announced the appointment of Jenny Gizzi as Chief Administrative Officer. In this ...

Subtle ligand modifications were shown to significantly boost emission efficiency, opening new pathways for designing advanced photoactive materials. These findings contribute valuable insight ...

US$2.21 loss per share (down from US$4.86 profit in 1Q 2024). We've discovered 1 warning sign about Ligand Pharmaceuticals. View them for free. Revenue exceeded analyst estimates by 20%.

The latest data from studies across Bayer's oncology and women's health portfolios will be presented at the upcoming 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place in ...

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL ...

In a bold, analog-first release, the band has pressed snippets from their forthcoming Mixes of a Lost World album onto acetate and distributed it to 24 independent record stores around the globe.

Here, we expand the repertoire of PROTAC compatible E3 ligases by identifying a novel small molecule scaffold targeting the ubiquitin E3 ligase KLHDC2 using a fluorescence polarization-based high ...

May 08, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today reported financial results for the three months ended March 31, 2025, and provided an operating forecast and ...